Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Bacil Pharma Ltd.

NSE : BSE : 524516 ISIN CODE : INE711D01018Industry : Pharmaceuticals

News

  • Bacil Pharma - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 23 Apr 2025 | 17:26 | Dion Global

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bacil Pharma L...more...

  • Bacil Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 23 Apr 2025 | 17:21 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bacil Ph...more...

  • Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025 21 Apr 2025 | 20:00 | Dion Global

    As of March 2025 0.20% is owned by Indian Promoters and 99.80% by Public. Top two Promoters holding highest number of shares of Bacil Pharma company ...more...

  • Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr 2025 | 16:58 | Dion Global

    Compliance Certificate under Reg 74(5) of SEBI (DP) Regulationmore...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Preferential Allotment Committee ('The Committee') Held On 24Th March 24 Mar 2025 | 21:01 | Dion Global

    Outcome of the Preferential Allotment Committee ( the Committee ) held on 24th March \r\n2025 for Allotment of 8 62 500 equity shares to non-promoter...more...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Preferential Allotment Committee ('The Committee') Held On 24Th March 24 Mar 2025 | 21:01 | Dion Global

    Outcome of the Preferential Allotment Committee ( the Committee ) held on 24th March \r\n2025 for Allotment of 8 62 500 equity shares to non...more...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Allotment 24 Mar 2025 | 20:53 | Dion Global

    Outcome of preferential Allotment committee held on 24 th march 2025more...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Allotment 12 Mar 2025 | 20:37 | Dion Global

    Allotment of 65 80 500 equity shares to non promoter on a preferential basis.more...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Preferential Allotment Committee ('The Committee') Held On 12Th\r\nMa 12 Mar 2025 | 20:33 | Dion Global

    Outcome of the Preferential Allotment Committee ( the Committee ) held on 12th\r\nMarch 2025 for Allotment of 65 80 500 equity shares to non-promoter...more...

  • Bacil Pharma - In-Principle Approval Granted By Stock Exchange 11 Mar 2025 | 19:17 | Dion Global

    In-Principle approval granted by stock exchangemore...

  • Bacil Pharma - In-Principle Approval Granted By Stock Exchange 11 Mar 2025 | 18:22 | Dion Global

    In-Principle Approval granted by stock exchange for issue of the 15 62 500 equity shares to non-promoters on preferential basis for cash consideratio...more...

  • Bacil Pharma - Integrated Filing (Financial) 11 Mar 2025 | 13:38 | Dion Global

    Integrated Filing of Financialsmore...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Resignation of Director 25 Feb 2025 | 18:11 | Dion Global

    Resignation of Mr. Mehul Hasmukhbhai Shah from the position of Executive Directormore...

  • Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024 21 Jan 2025 | 18:50 | Dion Global

    As of December 2024 10.60% is owned by Indian Promoters and 89.40% by Public. Top five Promoters holding highest number of shares of Bacil P...more...

  • Bacil Pharma - Outcome Of Board Meeting 21 Jan 2025 | 18:37 | Dion Global

    outcome of Board Meetingmore...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting 21 Jan 2025 | 18:31 | Dion Global

    Outcome of Board meetingmore...

  • Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 17 Jan 2025 | 17:51 | Dion Global

    Compliance certificate under reg 74(5) of SEBI (DP) Regulationmore...

  • Bacil Pharma - Board Meeting Intimation for 1) To Consider And Approve The Un-Audited Financial Results Along With Limited Re 13 Jan 2025 | 17:54 | Dion Global

    BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 inter alia to conside...more...

  • Bacil Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report 18 Nov 2024 | 13:09 | Dion Global

    Voting Result along with Scrutinizer report for EOGM dated 14.11.2024more...

  • Bacil Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM 14 Nov 2024 | 19:58 | Dion Global

    Proceeding of the EGM dated 14.11.2024more...

Enter Stock

DOW Jones40280.940.42%
Nasdaq17388.710.03%
S&P 5005536.520.20%
Nikkei 22535839.990.38%
Hang Seng21971.96-0.04%
Shanghai Composite3288.41-0.20%
Sensex80218.371.27%
NSE Index24328.51.20%
BSE 100LCTMC8972.671.24%
BSE Auto 500621.65%
BSE Bharat228402.691.60%
BSE CPSE 3692.441.98%

Commodity

Gold95244-0.50%
Silver974420.01%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 85.20(-0.44 %)
GBP/INR 113.43(-0.34 %)
EUR/INR 96.86(-0.27 %)
JPY/INR 0.59(-0.48 %)
CAD/INR 61.63(0.00 %)
HKD/INR 11.03(0.00 %)